H Qin, H Yu, J Sheng, D Zhang,
N Shen… - Advanced …, 2019 - Wiley Online Library
Vascular disrupting agents (VDAs) have great potential for cancer treatment. Poly (l‐
glutamic acid)‐combretastatin A4 conjugate (PLG‐CA4) is a novel class of VDAs. Though it …